Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Tetragon Financial Group Limited TFG Jan 15, 2026 17.05 0.00   
 Theon International Plc THEON Jan 15, 2026 31.65 +0.32   
 TKH Group NV TWEKA Jan 15, 2026 37.54 +1.46   
 TomTom NV TOM2 Jan 15, 2026 6.80 -0.51   
 TRIODOS BANK N.V. TRIO Jan 15, 2026 30.00 +0.54   
 UNIBAIL-RODAMCO SE Ordinary Shares URW Jan 15, 2026 92.26 +0.28   
 Unilever PLC UNA Jan 15, 2026 55.23 -1.07   
 Universal Music Group N.V. UMG Jan 15, 2026 21.88 -0.32   
 Value8 N.V. VALUE Jan 15, 2026 6.50 +0.78   
 Value8 N.V. 7% PRF PERPETUAL EUR 1.40 PREVA Jan 15, 2026 4.80 -1.03   
 Van Lanschot Kempen N.V VLK Jan 15, 2026 52.60 +1.74   
 Vivoryon Therapeutics N.V. VVY Jan 15, 2026 1.55 -1.53   
 Volta Finance Limited VTA Jan 15, 2026 6.70 +0.30   
 WDP WDP Jan 15, 2026 23.50 +1.03   
 Wereldhave NV WHA Jan 15, 2026 20.65 +0.24   
 Wolters Kluwer NV WKL Jan 15, 2026 88.00 +0.23   
 Younited Financial SA YOUNI Jan 15, 2026 7.40 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.